Premium
Coadministration of proton pump inhibitors and the efficacy of capecitabine in patients with advanced adenocarcinoma of the small bowel or ampulla of vater
Author(s) -
Altundag Kadri
Publication year - 2017
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.30553
Subject(s) - capecitabine , medicine , rabeprazole , oxaliplatin , gastroenterology , bevacizumab , cancer , adenocarcinoma , erlotinib , dihydropyrimidine dehydrogenase , oncology , colorectal cancer , pharmacology , fluorouracil , proton pump inhibitor , chemotherapy , thymidylate synthase , epidermal growth factor receptor
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom